Basile G, Neuville A, Martineau D, Delapierre B, Dubois S, Noel R, Durot E, Caillet A, Labouré G, Laribi K, Gros F-X, Bernard S, Mineur A, Borel C, Chartier L, Damaj G, Bouabdallah K, Galtier J. Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience. haematol [Internet]. 2020Sep.10 [cited 2026Apr.24];. Available from: https://haematologica.org/article/view/14142